ornithine transcarbamylase deficiency Archives

Pixabay

An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials

Post author:Kendall Mason
Post published:April 16, 2020
Post category:ornithine transcarbamylase deficiency / Urea cycle disorders
Post comments:0 Comments

Ornithine transcarbamylase (OTC) deficiency is a disorder that can cause comas, seizures, and death, making it necessary for those affected to seek treatment. Arcturus Therapeutics aims to give those with…

Gene Therapy: The New Frontier for Cancer

Post author:Rose Duesterwald
Post published:February 13, 2020
Post category:Beta Thalassemia / Cancer / ornithine transcarbamylase deficiency / Rare Disease / Severe Combined Immunodeficiency / Sickle cell anemia
Post comments:0 Comments

Gene therapy is the treatment of disease by way of the transfer of genetic material into cells. According to a recent article in Labiotech, an EU publication, gene therapy…

geralt / Pixabay

New Updates From Translate Bio in Drug Development for Cystic Fibrosis and OTC Deficiency

Post author:James Moore
Post published:January 8, 2019
Post category:Cystic Fibrosis / ornithine transcarbamylase deficiency
Post comments:0 Comments

According to a story from globenewswire.com, the messenger RNA therapeutics company Translate Bio recently released the latest updates in regards to two of its leading product candidates for the treatment…

An Ornithine Transcarbamylase Deficiency Treatment Has Been Approved for Clinical Trials

Gene Therapy: The New Frontier for Cancer

New Updates From Translate Bio in Drug Development for Cystic Fibrosis and OTC Deficiency

Let’s Work Together!

Keep Up to Date

Learn More

SIGN UP FOR OUR NEWSLETTER
Email Address